- some "boring" accounting proving we making at least what the PFS said we would out of the low grade current product.
Well, it will be found out at the end of October whether the PFS information can be met - information on the cash flow for the first sales will be significant. If the information on the cash flow from the PFS is lower, this always harbors disappointment.
- Forums
- ASX - By Stock
- E25
- The Dawn of EV
The Dawn of EV, page-333
-
- There are more pages in this discussion • 1,522 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add E25 (ASX) to my watchlist
(20min delay)
|
|||||
Last
23.5¢ |
Change
0.035(17.5%) |
Mkt cap ! $51.67M |
Open | High | Low | Value | Volume |
21.0¢ | 24.0¢ | 21.0¢ | $112.7K | 488.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 60014 | 23.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.5¢ | 65863 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 60014 | 0.235 |
1 | 39387 | 0.215 |
5 | 273670 | 0.210 |
1 | 10000 | 0.205 |
11 | 495004 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.245 | 65863 | 2 |
0.250 | 21957 | 3 |
0.255 | 19607 | 1 |
0.265 | 1010 | 1 |
0.270 | 20000 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
E25 (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online